Related Experiment Video
Updated: Apr 30, 2026

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
Severe pneumonia in children with influenza A-Staphylococcus aureus coinfection: case report
Pei Tao1, Zhigang Wang1, Yinghong Fan1
1Chengdu Women and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Sichuan, China.
Insights
Coinfection with influenza A virus and Staphylococcus aureus is rare in children but can cause severe pneumonia. Prompt recognition and treatment are crucial for recovery from this serious condition.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pulmonology
Background:
- Severe community-acquired pneumonia (CAP) can result from coinfection with influenza A virus and Staphylococcus aureus (S. aureus).
- This coinfection is uncommon but associated with rapid clinical decline and significant mortality.
- Pediatric cases of influenza-associated S. aureus coinfection present unique challenges in diagnosis and management.
Abstract:
Severe community-acquired pneumonia caused by coinfection with influenza A virus and Staphylococcus aureus (S. aureus) is rare but may lead to rapid clinical deterioration and high mortality. We report two pediatric cases of severe pneumonia associated with influenza A virus-S. aureus coinfection. Both patients initially presented with nonspecific influenza-like symptoms, followed by rapid progression to acute respiratory failure. One case was characterized by necrotizing pneumonia complicated by pneumothorax and empyema, with S. aureus isolated from respiratory specimens and pleural fluid. The other case developed S. aureus bloodstream infection, progressing to septic shock and multiple organ dysfunction syndrome. Both children required prolonged invasive mechanical ventilation and multidisciplinary intensive care, including targeted antimicrobial therapy, organ support, and surgical intervention. Antimicrobial treatment consisted of vancomycin with adjunctive linezolid for 4-6 weeks. Despite severe disease, both patients achieved clinical recovery and were discharged, although residual pulmonary abnormalities were observed on follow-up. These cases highlight the heterogeneous clinical presentations of influenza-associated S. aureus coinfection in children. Early recognition, timely optimization of antimicrobial therapy, and comprehensive supportive management are essential to improve outcomes in this potentially life-threatening condition.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
12:18Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....